Btk Is Required for an Efficient Response to Erythropoietin and for SCF-controlled Protection against TRAIL in Erythroid Progenitors

Regulation of survival, expansion, and differentiation of erythroid progenitors requires the well-controlled activity of signaling pathways induced by erythropoietin (Epo) and stem cell factor (SCF). In addition to qualitative regulation of signaling pathways, quantitative control may be essential to control appropriate cell numbers in peripheral blood. We demonstrate that Bruton's tyrosine kinase (Btk) is able to associate with the Epo receptor (EpoR) and Jak2, and is a substrate of Jak2. Deficiency of Btk results in reduced and delayed phosphorylation of the EpoR, Jak2, and downstream signaling molecules such as Stat5 and PLCγ1 as well as in decreased responsiveness to Epo. As a result, expansion of erythroid progenitors lacking Btk is impaired at limiting concentrations of Epo and SCF. In addition, we show that SCF induces Btk to interact with TNF-related apoptosis-inducing ligand (TRAIL)–receptor 1 and that lack of Btk results in increased sensitivity to TRAIL-induced apoptosis. Together, our results indicate that Btk is a novel, quantitative regulator of Epo/SCF-dependent expansion and survival in erythropoiesis.

[1]  C. Dai,et al.  Stem cell factor increases the expression of FLIP that inhibits IFNgamma -induced apoptosis in human erythroid progenitor cells. , 2003, Blood.

[2]  Asim Khwaja,et al.  The Src-selective Kinase Inhibitor PP1 Also Inhibits Kit and Bcr-Abl Tyrosine Kinases* , 2003, The Journal of Biological Chemistry.

[3]  T. Behrens,et al.  PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction , 2003, Nature Immunology.

[4]  O. Silvennoinen,et al.  The Pseudokinase Domain Is Required for Suppression of Basal Activity of Jak2 and Jak3 Tyrosine Kinases and for Cytokine-inducible Activation of Signal Transduction* , 2002, The Journal of Biological Chemistry.

[5]  H. Beug,et al.  Raf-1 Antagonizes Erythroid Differentiation by Restraining Caspase Activation , 2002, The Journal of experimental medicine.

[6]  W. Min,et al.  Etk/Bmx as a Tumor Necrosis Factor Receptor Type 2-Specific Kinase: Role in Endothelial Cell Migration and Angiogenesis , 2002, Molecular and Cellular Biology.

[7]  B. Habermann,et al.  Apoptosis Protection by the Epo Target Bcl-XL Allows Factor-Independent Differentiation of Primary Erythroblasts , 2002, Current Biology.

[8]  R. Woodland,et al.  BCR Engagement Induces Fas Resistance in Primary B Cells in the Absence of Functional Bruton’s Tyrosine Kinase1 , 2002, The Journal of Immunology.

[9]  J. Dupont,et al.  In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes : evidence for Fas-dependent apoptosis , 2002 .

[10]  F. Dammacco,et al.  Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma. , 2002, Blood.

[11]  G. Booker,et al.  The Solution Structure and Intramolecular Associations of the Tec Kinase Src Homology 3 Domain* , 2002, The Journal of Biological Chemistry.

[12]  Kendall W. Cradic,et al.  Competing modes of self‐association in the regulatory domains of Bruton's tyrosine kinase: Intramolecular contact versus asymmetric homodimerization , 2002, Protein science : a publication of the Protein Society.

[13]  S. Jacobsen.  Tumor Necrosis Factor ( TNF )-a Directly Inhibits Human Erythropoiesis In Vitro : Role of p 55 and p 75 TNF Receptors , 2002 .

[14]  J. Smith,et al.  Stem cell factor: laboratory and clinical aspects. , 2001, Blood reviews.

[15]  H. Lodish,et al.  Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. , 2001, Blood.

[16]  H. Beug,et al.  Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis , 2001, Oncogene.

[17]  J. Kinet,et al.  Interaction between the Btk PH Domain and Phosphatidylinositol-3,4,5-trisphosphate Directly Regulates Btk* , 2001, The Journal of Biological Chemistry.

[18]  Y. Baba,et al.  BLNK mediates Syk-dependent Btk activation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Vihinen,et al.  Intermolecular interactions between the SH3 domain and the proline‐rich TH region of Bruton's tyrosine kinase , 2001, FEBS letters.

[20]  Olivier Hermine,et al.  Caspase Activation Is Required for Terminal Erythroid Differentiation , 2001, The Journal of experimental medicine.

[21]  H. Kung,et al.  Signaling network of the Btk family kinases , 2000, Oncogene.

[22]  H. Mano,et al.  Stem cell factor induces phosphatidylinositol 3'-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells. , 2000, Blood.

[23]  A. Raza,et al.  Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspirates. , 2000, Blood.

[24]  F. Grosveld,et al.  An intrinsic but cell-nonautonomous defect in GATA-1-overexpressing mouse erythroid cells , 2000, Nature.

[25]  E. Alnemri,et al.  TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. , 2000, Blood.

[26]  D. Metcalfe,et al.  Kit signal transduction. , 2000, Hematology/oncology clinics of North America.

[27]  D. Olive,et al.  Tec kinases: a family with multiple roles in immunity. , 2000, Immunity.

[28]  R. Gregory,et al.  Signal transduction in the erythropoietin receptor system. , 1999, Experimental cell research.

[29]  S. Srinivasula,et al.  Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 , 1999, Nature.

[30]  H. Beug,et al.  The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. , 1999, Blood.

[31]  M. Tomonaga,et al.  Fas Antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-γ and tumor necrosis factor-α and potentiates apoptotic death , 1999 .

[32]  G. Stassi,et al.  Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. , 1999, Blood.

[33]  F. Uckun,et al.  Bruton’s Tyrosine Kinase as an Inhibitor of the Fas/CD95 Death-inducing Signaling Complex* , 1999, The Journal of Biological Chemistry.

[34]  M. Tomonaga,et al.  Fas antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates apoptotic death. , 1999, Experimental hematology.

[35]  H. Beug,et al.  A Novel Way to Induce Erythroid Progenitor Self Renewal: Cooperation of c-Kit with the Erythropoietin Receptor , 1999, Biological chemistry.

[36]  P. Kiener,et al.  A role for tumour necrosis factor‐α, Fas and Fas‐Ligand in marrow failure associated with myelodysplastic syndrome , 1998, British journal of haematology.

[37]  H. Kung,et al.  Tyrosine kinase expression profiles of chicken erythro-progenitor cells and oncogene-transformed erythroblasts. , 1998, Journal of biomedical science.

[38]  U. Ikeda,et al.  Tec and Jak2 Kinases Cooperate to Mediate Cytokine-Driven Activation of c- fos Transcription , 1998 .

[39]  J. Price,et al.  Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon gamma to produce erythroid cell apoptosis. , 1998, Blood.

[40]  U. Ikeda,et al.  Tec and Jak2 kinases cooperate to mediate cytokine-driven activation of c-fos transcription. , 1998, Blood.

[41]  P. Hawkins,et al.  Phosphatidylinositol 3-kinase-γ activates Bruton’s tyrosine kinase in concert with Src family kinases , 1997 .

[42]  T. Hirano,et al.  Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK , 1997, Oncogene.

[43]  H. Lodish,et al.  Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  L. Hoefsloot,et al.  Erythropoietin-induced activation of STAT5 is impaired in the myelodysplastic syndrome. , 1997, Blood.

[45]  H. Beug,et al.  The glucocorticoid receptor is a key regulator of the decision between self‐renewal and differentiation in erythroid progenitors , 1997, The EMBO journal.

[46]  P. Hawkins,et al.  Phosphatidylinositol 3-kinase-gamma activates Bruton's tyrosine kinase in concert with Src family kinases. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  G. Krystal,et al.  Early events in erythropoietin-induced signaling. , 1996, Experimental hematology.

[48]  F. Grosveld,et al.  Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre‐B cell stage. , 1996, The EMBO journal.

[49]  T. Kurosaki,et al.  BTK as a Mediator of Radiation-Induced Apoptosis in DT-40 Lymphoma B Cells , 1996, Science.

[50]  Rudolf Jaenisch,et al.  Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor , 1995, Cell.

[51]  F. Alt,et al.  Defective B cell development and function in Btk-deficient mice. , 1995, Immunity.

[52]  S. Jacobsen,et al.  Tumor necrosis factor (TNF)-alpha directly inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptors. , 1995, Blood.

[53]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.

[54]  E. Timmers,et al.  X-linked agammaglobulinemia. , 1991, Clinical immunology and immunopathology.

[55]  P. Leder,et al.  Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the SId mutant , 1991, Cell.

[56]  T. Graf,et al.  ts-oncogene-transformed erythroleukemic cells: a novel test system for purifying and characterizing avian erythroid growth factors. , 1987, Haematology and blood transfusion.

[57]  H. Zentgraf,et al.  Hormone-dependent terminal differentiation in vitro of chicken erythroleukemia cells transformed by ts mutants of avian erythroblastosis virus , 1982, Cell.